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	 Primary	Tumor	(T)	 Regional	Lymph	Nodes	(N)	 Distant	Metastasis	(M)	
Stage	0	 Tis	 N0	 M0	
Stage	I	 T1	 N0	 M0	
Stage	II	 T2	 N0	 M0	
Stage	IIIA	 T3	 N0	 M0	
Stage	IIIB	 T1-3	 N1	 M0	











































































































Age	(yrs),	mean	±	SD	 65	±	12	 66	±	11	 0.63	
Male,	n	(%)	 99	(37)	 57	(32)	 0.29	





































Clinical	Jaundice,	n	(%)	 24	(10)	 65	(40)	 <0.001	
Diagnostic	Laparoscopy,	n	(%)	 80	(30)	 71	(40)	 0.05	
Distant	Disease	on	Exploration,	n	(%)	 45	(17)	 63	(36)	 <0.001	
Attempted	Resection,	n	(%)	 235	(88)	 142	(79)	 0.01	





















EBL	(mL),	mean	±	SD	 337	±	346	 389	±	617	 0.37	
Major	Complication‡,	n	(%)	 37	(16)	 33	(21)	 0.25	


























































Lymphovascular	Invasion,	n	(%)	 53	(45)	 65	(64)	 0.01	
  11	
Perineural	Invasion,	n	(%)	 63	(53)	 62	(62)	 0.20	
#	Lymph	Nodes	Retrieved,	mean	±	SD	 4.8	±	5.5	 4.7	±	8.0	 0.82	
Any	Lymph	Node	Positive,	n	(%)	 86	(43)	 65	(60)	 0.009	
N1	(Regional)	Node	Positive,	n	(%)	 82	(41)	 60	(56)	 0.02	
N2	(Distant)	Node	Sampled,	n	(%)	 54	(23)	 20	(12)	 0.01	



































































































Variable	 HR	(95%	CI)	 p-value	 HR	(95%	CI)	 p-value	
Non-Incidental	vs.	
Incidental	
1.74	(1.26	-	2.40)	 0.001	 2.27	(1.15	-	4.46)	 0.02	
Clinical	Jaundice	 2.39	(1.57-3.64)	 <0.001	 0.79	(0.36	-	1.72)	 0.55	














































Lymph	Node	Positive	 1.93	(1.37	-	2.72)	 <0.001	 1.28	(0.68	-	2.39)	 0.44	
Lymphovascular	
Invasion	
2.33	(1.53	-	3.54)	 <0.001	 1.87	(0.96	-	3.66)	 0.07	
Perineural	Invasion	 2.34	(1.51	-	3.63)	 <0.001	 1.42	(0.71	-	2.84)	 0.32	
Adjuvant	
Chemotherapy	

























	 HR	(95%)	 p-value	 HR	(95%	CI)	 p-value	
Non-Incidental	vs.	Incidental	 3.01	(1.87	-	4.84)	 <0.001	 2.53	(1.21	-	4.23)	 0.01	
Clinical	Jaundice	 1.50	(0.84	–	2.69)	 0.17	 -	 -	









































Lymph	Node	Positive	 1.01	(0.62	-	1.63)	 0.98	 -	 -	
Lymphovascular	Invasion	 1.37	(0.71	-	2.65)	 0.35	 -	 -	
Perineural	Invasion	 1.49	(0.75	-	2.98)	 0.25	 -	 -	




































































































































































































































































































































	 Primary	Tumor	(T)	 Regional	Lymph	Nodes	(N)	 Distant	Metastasis	(M)	
Stage	0	 Tis	 N0	 M0	
Stage	I	 T1	 N0	 M0	
Stage	II	 T2	 N0	 M0	
Stage	IIIA	 T3	 N0	 M0	
Stage	IIIB	 T1-3	 N1	 M0	





































































































Age	(yrs),	mean	±	SD	 65	±	12	 66	±	11	 0.63	
Male,	n	(%)	 99	(37)	 57	(32)	 0.29	





































Clinical	Jaundice,	n	(%)	 24	(10)	 65	(40)	 <0.001	
Diagnostic	Laparoscopy,	n	(%)	 80	(30)	 71	(40)	 0.05	
Distant	Disease	on	Exploration,	n	(%)	 45	(17)	 63	(36)	 <0.001	
Attempted	Resection,	n	(%)	 235	(88)	 142	(79)	 0.01	





















EBL	(mL),	mean	±	SD	 337	±	346	 389	±	617	 0.37	
Major	Complication‡,	n	(%)	 37	(16)	 33	(21)	 0.25	


























































Lymphovascular	Invasion,	n	(%)	 53	(45)	 65	(64)	 0.01	
Perineural	Invasion,	n	(%)	 63	(53)	 62	(62)	 0.20	
#	Lymph	Nodes	Retrieved,	mean	±	SD	 4.8	±	5.5	 4.7	±	8.0	 0.82	
Any	Lymph	Node	Positive,	n	(%)	 86	(43)	 65	(60)	 0.009	
N1	(Regional)	Node	Positive,	n	(%)	 82	(41)	 60	(56)	 0.02	
N2	(Distant)	Node	Sampled,	n	(%)	 54	(23)	 20	(12)	 0.01	

































































































	 HR	(95%	CI)	 p-value	 HR	(95%	CI)	 p-value	
Non-Incidental	vs.	
Incidental	
1.74	(1.26	-	2.40)	 0.001	 2.27	(1.15	-	4.46)	 0.02	
Clinical	Jaundice	 2.39	(1.57-3.64)	 <0.001	 0.79	(0.36	-	1.72)	 0.55	














































Lymph	Node	Positive	 1.93	(1.37	-	2.72)	 <0.001	 1.28	(0.68	-	2.39)	 0.44	
Lymphovascular	
Invasion	
2.33	(1.53	-	3.54)	 <0.001	 1.87	(0.96	-	3.66)	 0.07	
Perineural	Invasion	 2.34	(1.51	-	3.63)	 <0.001	 1.42	(0.71	-	2.84)	 0.32	
Adjuvant	
Chemotherapy	


























	 HR	(95%)	 p-value	 HR	(95%	CI)	 p-value	
Non-Incidental	vs.	Incidental	 3.01	(1.87	-	4.84)	 <0.001	 2.53	(1.21	-	4.23)	 0.01	
Clinical	Jaundice	 1.50	(0.84	–	2.69)	 0.17	 -	 -	









































Lymph	Node	Positive	 1.01	(0.62	-	1.63)	 0.98	 -	 -	
Lymphovascular	Invasion	 1.37	(0.71	-	2.65)	 0.35	 -	 -	
Perineural	Invasion	 1.49	(0.75	-	2.98)	 0.25	 -	 -	
Adjuvant	Chemotherapy	 0.45	(0.26	-	0.77)	 0.004	 0.48	(0.27	-	0.84)	 0.01	
ᐩ	Excludes	AJCC	Stages	I,	II,	and	IV,	and	aborted/R2	resections	
‡	Insufficient	number	of	patients	for	analysis	
HR,	hazard	ratio;	CI,	confidence	interval;	AJCC,	American	Joint	Committee	on	Cancer	
	
	
	
	
	
